Coagulation Activation Is Associated with Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Dependent Reactive Oxygen Species Generation in Hemodialysis Patients
- 1 March 2012
- journal article
- research article
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 16 (5) , 428-439
Abstract
Aims: This study investigated on (i) the role of gp91phox/NOX2 in reactive oxygen species (ROS) generation in hemodialysis (HD) patients, and (ii) the link between clotting activation and ROS production in this setting. Results: The study was performed on peripheral blood mononuclear cells (PBMCs) isolated from HD patients randomized to polysulphon/polyamide (S-group, n=30) or ethylene-vinyl-alcohol (EVAL) membrane (E-group, n=30) treatment and from healthy subjects (control group, n=15). ROS generation was increased in PBMCs of HD patients compared with healthy subjects. S-group showed higher levels of intracellular ROS generation than control, whereas E-group did not. In addition, S-group displayed an increase in nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity compared with E-group and healthy subjects. A further increase in NADPH activity shortly after HD treatment was observed only in S-group. The plasma levels of the prothrombin fragment F1+2, a marker of in vivo clotting activation, were significantly higher in S-group than in E-group. Moreover, a heightened thrombin generation was recorded in the plasma of S-group. Intracellular ROS production correlated with NADPH oxidase activity and coagulation priming in HD patients. The in vitro validation study demonstrated that incubation of PBMCs with activated FX induced a significant increase in intracellular ROS production, superoxide generation, and gp91phox/NOX2 expression. Innovation: The pivotal role of NADPH oxidase in the upregulation of ROS in HD patients makes this enzyme a potential target for therapeutic intervention in the treatment of HD-related oxidative stress. Conclusion: The EVAL membrane, by reducing clotting activation, inhibits gp91phox/NOX2-related ROS production in HD patients. Antioxid. Redox Signal. 16, 428–439.Keywords
This publication has 32 references indexed in Scilit:
- Biocompatibility of heparin‐grafted hemodialysis membranes: Impact on monocyte chemoattractant protein‐1 circulating level and oxidative statusHemodialysis International, 2010
- Nox Activator 1Circulation, 2010
- Analysis method and characterization of the antioxidant capacity of vitamin E-interactive polysulfone hemodialyzersActa Biomaterialia, 2009
- Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease PatientClinical Journal of the American Society of Nephrology, 2008
- Recollections on thrombin generationJournal of Thrombosis and Haemostasis, 2008
- Coagulation Cascade Activation Causes CC Chemokine Receptor-2 Gene Expression and Mononuclear Cell Activation in Hemodialysis PatientsJournal of the American Society of Nephrology, 2005
- Oxidative stress in hemodialysis patients: Is NADPH oxidase complex the culprit?Kidney International, 2002
- Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox‐dependent pathway and independent of phosphoinositide 3‐kinaseThe FASEB Journal, 2001
- Role of Cytokines, Tyrosine Kinase, and Protein Kinase C on Production of Superoxide and Induction of Scavenging Enzymes in Human LeukocytesClinical Immunology and Immunopathology, 1996
- Establishing the Relationship between Complement Activation and Stimulation of Phagocyte Oxidative Metabolism in Hemodialyzed Patients: A Randomized Prospective StudyNephron, 1991